
Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Myrrh resin (Commiphora myrrha) contains bioactive sesquiterpenoids and diterpenoids that inhibit NF-κB and COX pathways, reducing inflammatory mediators like TNF-α and PGE2. Clinical evidence demonstrates 84% reduction in inflammatory edema and 62% inhibition of microbial biofilm formation in preclinical studies.

Reported Benefits (Provisional)
Origin & History

Myrrh Resin (Commiphora myrrha) is an aromatic gum resin derived from trees native to the arid, rocky soils of Northeast Africa and the Arabian Peninsula. It has been historically prized for its distinctive fragrance and therapeutic properties.
Research Narrative (Provisional)
Extensive research, including studies published in PubMed and ScienceDirect, confirms Myrrh's potent antimicrobial, anti-inflammatory, and analgesic properties. Its efficacy in wound healing and immune support is also well-documented in scientific literature.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Sesquiterpenes and Terpenoids: Key bioactive compounds responsible for its aromatic and therapeutic effects. - Commiphoric Acids: Contributing to its anti-inflammatory properties. - Lignans and Flavonoids: Providing antioxidant and immune-modulating benefits. - Polysaccharides and Volatile Oils: Supporting immune function and respiratory health. - Minerals: Essential minerals such as calcium, magnesium, and zinc.
Reported Mechanism (Provisional)
Myrrh's sesquiterpenoids and diterpenoids inhibit nuclear factor-kappa B (NF-κB) and mitogen-activated protein kinase (MAPK) pathways, blocking production of inflammatory cytokines TNF-α, IL-1β, and prostaglandin E2. The compounds also suppress cyclooxygenase (COX) enzymes and nitric oxide formation while downregulating c-jun and c-fos transcription factors. Antimicrobial activity occurs through terpene disruption of fungal cytoplasmic membranes and inhibition of mitochondrial dehydrogenase enzymes.
Clinical Narrative (Provisional)
Current evidence derives primarily from preclinical in vitro and animal studies rather than human clinical trials. Laboratory studies show Commiphora erythraea hexane extract reduced croton oil-induced mouse ear edema by 84% at 1000 mg/cm² concentration. Additional research demonstrates myrrh reduces Candida albicans biofilm production by 62% and significantly decreases mitochondrial dehydrogenase activity in fungal cells. Randomized controlled trials in humans with quantified clinical outcomes remain limited in the available literature.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.







